First Trust Advisors LP Has $5.48 Million Position in Cabot Co. (NYSE:CBT)

First Trust Advisors LP cut its holdings in shares of Cabot Co. (NYSE:CBT - Free Report) by 17.4% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 60,043 shares of the specialty chemicals company's stock after selling 12,619 shares during the quarter. First Trust Advisors LP owned 0.11% of Cabot worth $5,483,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently bought and sold shares of the business. American Century Companies Inc. boosted its position in Cabot by 8.5% during the fourth quarter. American Century Companies Inc. now owns 1,323,347 shares of the specialty chemicals company's stock valued at $120,835,000 after purchasing an additional 103,380 shares during the last quarter. Sei Investments Co. lifted its stake in shares of Cabot by 6.0% in the 4th quarter. Sei Investments Co. now owns 942,273 shares of the specialty chemicals company's stock valued at $86,039,000 after purchasing an additional 53,090 shares during the last quarter. Invesco Ltd. lifted its stake in shares of Cabot by 7.1% in the 4th quarter. Invesco Ltd. now owns 845,261 shares of the specialty chemicals company's stock valued at $77,181,000 after purchasing an additional 55,905 shares during the last quarter. Copeland Capital Management LLC boosted its holdings in Cabot by 21.6% in the fourth quarter. Copeland Capital Management LLC now owns 761,372 shares of the specialty chemicals company's stock worth $69,521,000 after purchasing an additional 135,119 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. increased its position in Cabot by 0.4% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 710,608 shares of the specialty chemicals company's stock worth $64,886,000 after buying an additional 3,175 shares during the last quarter. Hedge funds and other institutional investors own 93.18% of the company's stock.

Cabot Stock Performance

CBT traded down $4.24 during midday trading on Tuesday, reaching $73.26. The company's stock had a trading volume of 162,367 shares, compared to its average volume of 395,582. Cabot Co. has a twelve month low of $72.01 and a twelve month high of $117.46. The stock has a market cap of $3.97 billion, a P/E ratio of 9.79, a PEG ratio of 0.74 and a beta of 0.91. The company has a fifty day simple moving average of $80.96 and a 200 day simple moving average of $92.06. The company has a current ratio of 2.00, a quick ratio of 1.29 and a debt-to-equity ratio of 0.72.

Cabot (NYSE:CBT - Get Free Report) last released its earnings results on Monday, May 5th. The specialty chemicals company reported $1.90 EPS for the quarter, beating the consensus estimate of $1.86 by $0.04. Cabot had a net margin of 10.60% and a return on equity of 26.79%. The firm had revenue of $936.00 million during the quarter, compared to analysts' expectations of $1.02 billion. During the same period in the prior year, the company earned $1.78 EPS. The business's quarterly revenue was down 8.1% compared to the same quarter last year. Research analysts expect that Cabot Co. will post 7.57 earnings per share for the current year.

Cabot Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, June 13th. Investors of record on Friday, May 30th will be given a dividend of $0.45 per share. This is an increase from Cabot's previous quarterly dividend of $0.43. This represents a $1.80 dividend on an annualized basis and a yield of 2.46%. Cabot's dividend payout ratio (DPR) is 22.84%.

Wall Street Analysts Forecast Growth

Several analysts have recently issued reports on CBT shares. UBS Group decreased their price target on Cabot from $93.00 to $83.00 and set a "neutral" rating for the company in a research note on Monday, April 7th. JPMorgan Chase & Co. lowered their price target on Cabot from $105.00 to $85.00 and set an "underweight" rating on the stock in a report on Friday, February 21st. StockNews.com upgraded shares of Cabot from a "hold" rating to a "buy" rating in a research note on Thursday, April 17th. Finally, Mizuho lowered their target price on shares of Cabot from $122.00 to $110.00 and set an "outperform" rating on the stock in a research note on Tuesday, January 7th.

Cabot Company Profile

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.